The efficacy and role of mobosetinib/mobosetinib, and how long it usually takes to be effective

Mobocertinib (Mobocertinib) is an oral drug that is a tyrosine kinase inhibitor. It is mainly used to treat non-small cell lung cancer (NSCLC) with specific gene mutations. Mobotinib blocks the growth and spread of tumor cells by inhibiting the activity of specific tyrosine kinases in tumor cells. Mobosetinib has shown significant anti-tumor activity in certainEGFR mutation-positive NSCLC patients in clinical trials.

Mobosetinib can prolong patient survival and reduce the risk of disease progression. The drug also improves patients' quality of life and reduces related symptoms. The duration of effectiveness of the drug varies from individual to individual. Generally, the duration of effectiveness of mobosetinib depends on the patient's disease status and response to treatment. The doctor will evaluate the patient's specific situation and adjust the treatment plan if necessary. If the patient is receiving mobotinib treatment, it is recommended to work closely with the doctor and conduct regular follow-up visits and examinations to ensure the best treatment effect.

Mobosetinib The original drug has been launched in China, but it is not included in the medical insurance. The price of the common specification 40mg*112 pills per box is about 40,000 yuan, which is very high. The Hong Kong clinical version specification 40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). Generic drugs of Mobotinib have also been put on the market for sale overseas. Its pharmaceutical ingredients are basically the same as those of the original drugs at home and abroad. For example, the production specifications of Laos Pharmaceutical Factory 40mg*120 pills per box may be more than 4,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.